These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 9740509

  • 1. S-100 protein-positive dendritic cells in follicular lesions of the thyroid.
    Hirokawa M, Shimizu M, Manabe T, Sonoo H, Harada T.
    APMIS; 1998 Jul; 106(7):704-8. PubMed ID: 9740509
    [Abstract] [Full Text] [Related]

  • 2. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 3. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Satacińska-Los E, Kulig A, Włoch J.
    Pol J Pathol; 2005 Jun; 56(1):27-35. PubMed ID: 15921011
    [Abstract] [Full Text] [Related]

  • 4. Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Sałacińska-Loś E, Kulig A, Włoch J.
    Pol J Pathol; 2004 Jun; 55(4):133-41. PubMed ID: 15757200
    [Abstract] [Full Text] [Related]

  • 5. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Sałacińska-Loś E, Kulig A, Włoch J.
    Pol J Pathol; 2004 Jun; 55(4):143-8. PubMed ID: 15757201
    [Abstract] [Full Text] [Related]

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW.
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS, LiVolsi VA, Furth EE, Pasha TL, Putt ME, Baloch ZW.
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [Abstract] [Full Text] [Related]

  • 8. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Włoch J, Sałacińska-Los E, Kulig A, Jarzab B.
    Pol J Pathol; 2004 Aug; 55(4):149-53. PubMed ID: 15757202
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Papillary carcinoma occurring within an adenomatous goiter of the thyroid gland in Cowden's disease.
    Kameyama K, Takami H, Miyajima K, Mimura T, Hosoda Y, Ito K, Ito K.
    Endocr Pathol; 2001 Aug; 12(1):73-6. PubMed ID: 11478271
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of AgNOR staining in thyroid cytology.
    Shechtman L, Koren R, Horowitz A, Shechtman I, Halpern M, Gal R.
    Anal Quant Cytol Histol; 1998 Jun; 20(3):187-91. PubMed ID: 9642445
    [Abstract] [Full Text] [Related]

  • 13. [Immunohistochemical study of borderline thyroid lesions with special reference to relationships among nuclear features, type IV collagen and malignancy of follicular lesions].
    Takeda K, Yamada N, Asano G.
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Dec; 96(12):2057-64. PubMed ID: 8295068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions.
    Kodama M, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S.
    Jpn J Clin Oncol; 1994 Apr; 24(2):66-73. PubMed ID: 7512670
    [Abstract] [Full Text] [Related]

  • 16. [Nodular goiter and thyroid cancer].
    Valdina EA.
    Vestn Khir Im I I Grek; 1997 Apr; 156(2):23-6. PubMed ID: 9235760
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.
    Soares P, Cameselle-Teijeiro J, Sobrinho-Simões M.
    Histopathology; 1994 Mar; 24(3):205-10. PubMed ID: 8200621
    [Abstract] [Full Text] [Related]

  • 18. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.
    Shingu K, Fujimori M, Ito K, Hama Y, Kasuga Y, Kobayashi S, Itoh N, Amano J.
    Endocr J; 1998 Feb; 45(1):35-43. PubMed ID: 9625444
    [Abstract] [Full Text] [Related]

  • 19. [Pathology of benign thyroid tumor].
    Kameyama K, Ito K, Takami H.
    Nihon Rinsho; 2007 Nov; 65(11):1973-8. PubMed ID: 18018557
    [Abstract] [Full Text] [Related]

  • 20. Observer variation of encapsulated follicular lesions of the thyroid gland.
    Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, Tsujimoto M, Kakudo K.
    Am J Surg Pathol; 2002 Nov; 26(11):1508-14. PubMed ID: 12409728
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.